GEHC

GE HealthCare Technologies
D

GEHC

Arincen60/100B
82.385
USD
-1.36
(-1.62%)
Post Trading·82.380USD-0.005(-0.01%)
Fair value76.47Plus+8%51Price 82.39119
Q4 FY2026 · Earnings report
EPS estimate 1.55Revenue estimate 5.92B
OverviewFinancialsForecastEarningsDividendsCompany

GE HealthCare Technologies revenue 2019–2026

GE HealthCare Technologies's revenue in Q3 FY2026, the three months to 30 September 2026, was 5.51B USD, up 7.2% on the same quarter a year before. GE HealthCare Technologies's revenue over the last twelve months was 20.61B USD, up 1.8% on the twelve months before. In fiscal year 2025 it was 20.63B USD, up 4.8% on the year before.

Last updated 7 Nov 2026 · Next report 3 Feb 2027

Revenue

Growth

Fiscal yearPeriod endingRevenueGrowthGross profitNet income
TTM30 Sept 202620.61B+1.82%8.92B1.76B
FY202531 Dec 202520.63B+4.84%8.25B2.08B
FY202431 Dec 202419.67B+0.61%8.21B1.99B
FY202331 Dec 202319.55B+6.60%7.92B1.57B
FY202231 Dec 202218.34B+4.30%7.18B1.92B
FY202131 Dec 202117.59B+2.45%7.17B2.25B
FY202031 Dec 202017.16B+3.19%6.77B13.85B
FY201931 Dec 201916.63B—6.55B1.52B

Figures in USD. Shares and EPS are adjusted for stock splits. Quarterly growth is on the same quarter a year before; TTM is the last four quarters.

GE HealthCare Technologies revenue growth by segment

FY2025 against FY2024

Imaging9.25B
+4.4%
PCS3.09B
-1.2%
PDx2.90B
+15.6%

GE HealthCare Technologies revenue by segment over time

Imaging PCS PDx Ultrasound
Fiscal yearImagingPCSPDxUltrasound
FY20259.25B +4.4%3.09B -1.2%2.90B +15.6%—
FY20248.86B -16.3%3.13B -0.5%2.51B +8.8%—
FY202310.58B 3.14B 2.31B 3.46B

See also:Net income,EPS,Shares outstanding,Operating income,Cash on hand,Total debt,Free cash flow,Income statement

Common questions about GE HealthCare Technologies's revenue

Source: Financial Modeling Prep

Smarter Decisions,Together
FacebookTwitterYoutubeInstagramLinkedIn
App Store
iOS
Google Play
Android

Risk Disclosure: Trading in financial instruments involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks. Never invest money you cannot afford to lose, and carefully assess the suitability of complex products such as CFDs and derivatives in light of your financial situation. Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed. Arincen would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes.

Arincen and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website. It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Arincen and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website. Arincen may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.

© 2026 - Arincen L.L.C-FZ - License No. 2420098.01. All Rights Reserved.